Chemoprevention of pancreatic ductal carcinoma by targeting for GST-π

靶向 GST-π 化学预防胰腺导管癌

• 批准号: 21790677
• 负责人: HAYASHI Tsuyoshi
• 金额: $ 2.75万
• 依托单位: Sapporo Medical University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Young Scientists (B)
• 财政年份: 2009
• 资助国家: 日本
• 起止时间: 2009 至 2010
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21790677/
• 关键词: 医療・福祉; 癌

As we have finished the preparation of drug for double blinded study, we are now conducting a randomized controlled trial for evaluating of suppressive effect of sulindac on branch duct type intraductal papillary mucinous neoplasms (BD-IPMN). We believe that our future results will contribute to the establishment of the chemoprevention of pancreatic ductal carcinoma derived from BD-IPMN.

由于我们已经完成了双盲研究的药物制备，我们现在正在进行一项随机对照试验，以评估舒林酸对分支导管型导管内乳头状黏液性肿瘤（BD-IPMN）的抑制作用。我们相信，我们未来的研究结果将有助于建立胰腺导管癌的化学预防来自BD-IPMN。

项目成果

Suppressive effect of sulindac on branch duct-intraductal papillary mucinous neoplasms.

舒林酸对分支导管-导管内乳头状粘液性肿瘤的抑制作用。

• 发表时间: 2009
• 期刊: J Gastroenterol 44(9)
• 作者: Hayashi T;Ishiwatari H;Ihara H;Kawano Y;Takada K;Miyanishi K;Kobune M;Takimoto R;Sonoda T;Takayama T;Kato J;Niitsu Y
• 通讯作者: Niitsu Y